ArticleScientific reports2020

Combined lentiviral- and RNA-mediated CRISPR/Cas9 delivery for efficient and traceable gene editing in human hematopoietic stem and progenitor cells.

David Yudovich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.